Join Us for a Free Webinar with Dr. Dianna Milewicz, MD, PhD! Explore how genetic testing and family screening (known as “cascade screening”) can make a real difference in detecting and managing genetic aortic disorders early on.
In this informative session, Dr. Milewicz will discuss how these tools help identify risks for individuals and their families, allowing for proactive steps in care and health planning.
Whether you’re a healthcare professional, patient, or family member, this webinar offers valuable insights into the life-saving potential of genetic testing. Don’t miss out on this opportunity—registration is free but required.
To accommodate those unable to join us live, the event will be recorded and shared afterwards on our YouTube channel. Even if you are unable to attend, you can still submit questions, which we will address during the event. Please send your questions to info@gadacanada.ca.
ABOUT THE SPEAKER: Dr. Dianna M. Milewicz, MD, PhD, Medical Geneticist, UTHealth Houston, Past Chair and current member of GADA – Professional Advisory Board Executive Chair, Montalcino Aortic Consortium
Dr. Milewicz, is the President George H.W. Bush Chair of Cardiovascular Medicine, Director of the Division of Medical Genetics and Vice-Chair of the Department of Internal Medicine at the University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School. She completed her postgraduate training in internal medicine, specialized further in medical genetics, and forged a career in translational studies focused on genetic predisposition to vascular diseases. She has received numerous honors and awards for her research, including the Antoine Marfan Award, the Doris Duke Distinguished Clinical Scientist Award and the University of Texas Presidential Scholars Award for Excellence in Research. She has been inducted into the American Society of Clinical Investigation and the Association of American Physicians. Dr. Milewicz is the Past Chair of GADA Professional Advisory Board (PAB) and continues to provide her expertise as an active member of the PAB. Dr. Milewicz is the Executive Chair of the Montalcino Aortic Consortium (MAC), managing the largest genetic Aortopathy research registry in the world.
EVENT DISCLAIMER: The contents of this GADA Canada hosted virtual event, such as presentations, discussions, text, graphics, images, and other materials created or presented by GADA Canada and by others appearing in the event at the invitation of GADA Canada are for educational and informational purposes only. GADA Canada is a voluntary health organization and is not engaged in rendering medical advice or recommendations on diagnosis or treatment of genetic aortic disorders. The content within this virtual event or the GADA website, www.gadacanada.ca, should not replace necessary consultations with qualified health care professionals for medical advice, diagnosis, or treatment.
Genetic aortic disorders are complex, multi-system disorders that can only be properly diagnosed and managed by skilled and trained health care professionals. The manifestations and severity of these disorders vary greatly among individuals and require personalized medical management. None of the medications, courses of treatment or lifestyle & activity recommendations discussed in this virtual event should be undertaken without being discussed with your physician.